Pleasure @Steini
I have to say I missed the boat on IMU at 2.9c last year - I had no understanding of biotech back then and perhaps a moderately better understanding now.
I feel like IVX essentially becomes the listed front from which RMW commercialises Photosoft globally - IVX allows Cho to move from funding trials himself (which he has done completely so far, with some help from the IVX washing machine) to progressively out-licensing to IVX in broader jurisdictions as the treatment progressively generates clinical trial outcomes.
Add to My Watchlist
What is My Watchlist?
